Acute lower respiratory tract infection
Disease

Medical Tests (56)
Diagnostic Testing (11)
Disease Management Testing (6)
Other Supportive/Alternative Tests (39)
Bacterial Culture, Lower Respiratory
7
Note:

If Lower respiratory pathogen panel is negative and does not include most common pathogens.

Bacterial Culture, Sputum
7
Note:

As an alternative to Lower respiratory pathogen panel if negative and might not have all targets.

Basic Metabolic Panel (BMP)
7
Note:

Alternative to Comprehensive Metabolic Panel.

Respiratory Pathogen (Pneumonia) Panel with Antibiotic Resistance Genes, Molecular
7
Note:

If minirespiratory pathogen panel is negative and does not give the diagnosis.

Respiratory Pathogen Panel Including SARS-CoV-2, Molecular
7
Note:

Can be used as an alternative to Lower Respiratory Pathogen Panel as it cand be difficult to collect sputum or bronchial wash.

Respiratory Viral Culture
7
Note:

Used as an alternative to Lower respiratory pathogen panel if negative and might not contain all targets.

Anti-SARS-CoV-2 (Coronavirus), IgG and IgM
6
Note:

Used for evaluation of immunity to SARS CoV-2; coronavirus.

Antibiotic Resistance, Genotyping
6
Note:

Usually part of the syndromic (infectious disease pathogen) panel by molecular.

Chlamydia Pneumoniae, Molecular
6
Note:

Alternative to RPP panel.

Chlamydia pneumoniae, Culture
6
Note:

Alternative to RPP panel, or molecular method.

Coronavirus by Molecular Method
6
Note:

Used for diagnosis of pneumonia caused by the new coronavirus strain SARS-CoV-2 if indicated.

Gentamicin, Peak, Serum
6
Note:

Therapy monitoring.

Gentamicin, Trough, Serum
6
Note:

Therapy monitoring.

Influenza Virus Type A and B SARS-CoV-2, PCR
6
Note:

Alternative to minirespiratory panel.

Legionella Culture
6
Note:

Rule out Legionella infection if not included in the Lower respiratory pathogen panel.

Mycoplasma pneumoniae Antibody, IgG
6
Note:

Rule out M. pneumoniae infection.

Mycoplasma pneumoniae, Molecular
6
Note:

If not part of the extended respiratory pathogen panel.

SARS-CoV-2 (COVID-19) Coronavirus, Molecular
6
Note:

Rule out SARS-CoV-2 infection.

Sulfamethoxazole, Serum
6
Note:

Therapy monitoring.

Tobramycin, Peak, Serum
6
Note:

Therapy monitoring.

Tobramycin, Serum
6
Note:

Therapy monitoring.

Tobramycin, Trough, Serum
6
Note:

Therapy monitoring.

Vancomycin, Peak, Serum
6
Note:

Therapy monitoring.

Vancomycin, Random, Serum
6
Note:

Therapy monitoring.

Vancomycin, Trough, Serum
6
Note:

Therapy monitoring.

Influenza Virus Type A and B, SARS-CoV-2 (COVID-19) Antibody or Antigen
5
Note:

Alternative to mini respiratory panel including Flu A/B, RSV and SARS-CoV-2.

Legionella pneumophila, Molecular
5
Note:

If not part of the respiratory pathogen panel and legionella infection is suspected.

Mini Respiratory Pathogen Panel (Influenza A and B and SARS-CoV-2), Molecular
5
Note:

Alternative to mini respiratory panel including Flu A/B, RSV and SARS-CoV-2.

Respiratory Syncytial Virus (RSV), Molecular
5
Note:

Rule out RSV infection. Usually ordered in panel with Flu A and B.

SARS-CoV-2 (COVID-19) Coronavirus, Genotyping
5
Note:

Monitor SARS-CoV-2 virus variants.

ICD10
A15.7Primary respiratory tuberculosis
B37Candidiasis
B37.8Candidiasis of other sites
B96Other bacterial agents as the cause of diseases classified elsewhere
B96.0Mycoplasma pneumoniae [M. pneumoniae] as the cause of diseases classified elsewhere
B96.83
J10.1Influenza due to other identified influenza virus with other respiratory manifestations
J12.1Respiratory syncytial virus pneumonia
J20Acute bronchitis
J20.5Acute bronchitis due to respiratory syncytial virus
J20.9Acute bronchitis, unspecified
J21Acute bronchiolitis
J22Unspecified acute lower respiratory infection
J47.0Bronchiectasis with acute lower respiratory infection
J80Acute respiratory distress syndrome
J96.0Acute respiratory failure
R05Cough
R06.03Acute respiratory distress
R50Fever of other and unknown origin
R50.9Fever, unspecified
R84Abnormal findings in specimens from respiratory organs and thorax
Z16Resistance to antimicrobial drugs

Additional ICD10
B37.0Candidal stomatitis
B37.1Pulmonary candidiasis
B37.2Candidiasis of skin and nail
B37.3Candidiasis of vulva and vagina
B37.31
B37.32
B37.4Candidiasis of other urogenital sites
B37.41Candidal cystitis and urethritis
B37.42Candidal balanitis
B37.49Other urogenital candidiasis
B37.5Candidal meningitis
B37.6Candidal endocarditis
B37.7Candidal sepsis
B37.8Candidiasis of other sites
B37.81Candidal esophagitis
B37.82Candidal enteritis
B37.83Candidal cheilitis
B37.84Candidal otitis externa
B37.89Other sites of candidiasis
B37.9Candidiasis, unspecified
B96.0Mycoplasma pneumoniae [M. pneumoniae] as the cause of diseases classified elsewhere
B96.1Klebsiella pneumoniae [K. pneumoniae] as the cause of diseases classified elsewhere
B96.2Escherichia coli [E. coli ] as the cause of diseases classified elsewhere
B96.20Unspecified Escherichia coli [E. coli] as the cause of diseases classified elsewhere
B96.21Shiga toxin-producing Escherichia coli [E. coli] [STEC] O157 as the cause of diseases classified elsewhere
B96.22Other specified Shiga toxin-producing Escherichia coli [E. coli] [STEC] as the cause of diseases classified elsewhere
B96.23Unspecified Shiga toxin-producing Escherichia coli [E. coli] [STEC] as the cause of diseases classified elsewhere
B96.29Other Escherichia coli [E. coli] as the cause of diseases classified elsewhere
B96.3Hemophilus influenzae [H. influenzae] as the cause of diseases classified elsewhere
B96.4Proteus (mirabilis) (morganii) as the cause of diseases classified elsewhere
B96.5Pseudomonas (aeruginosa) (mallei) (pseudomallei) as the cause of diseases classified elsewhere
B96.6Bacteroides fragilis [B. fragilis] as the cause of diseases classified elsewhere
B96.7Clostridium perfringens [C. perfringens] as the cause of diseases classified elsewhere
B96.8Other specified bacterial agents as the cause of diseases classified elsewhere
B96.81Helicobacter pylori [H. pylori] as the cause of diseases classified elsewhere
B96.82Vibrio vulnificus as the cause of diseases classified elsewhere
B96.83
B96.89Other specified bacterial agents as the cause of diseases classified elsewhere
J20.0Acute bronchitis due to Mycoplasma pneumoniae
J20.1Acute bronchitis due to Hemophilus influenzae
J20.2Acute bronchitis due to streptococcus
J20.3Acute bronchitis due to coxsackievirus
J20.4Acute bronchitis due to parainfluenza virus
J20.5Acute bronchitis due to respiratory syncytial virus
J20.6Acute bronchitis due to rhinovirus
J20.7Acute bronchitis due to echovirus
J20.8Acute bronchitis due to other specified organisms
J20.9Acute bronchitis, unspecified
J21.0Acute bronchiolitis due to respiratory syncytial virus
J21.1Acute bronchiolitis due to human metapneumovirus
J21.8Acute bronchiolitis due to other specified organisms
J21.9Acute bronchiolitis, unspecified
R50.2Drug induced fever
R50.8Other specified fever
R50.81Fever presenting with conditions classified elsewhere
R50.82Postprocedural fever
R50.83Postvaccination fever
R50.84Febrile nonhemolytic transfusion reaction
R50.9Fever, unspecified
R84.0Abnormal level of enzymes in specimens from respiratory organs and thorax
R84.1Abnormal level of hormones in specimens from respiratory organs and thorax
R84.2Abnormal level of other drugs, medicaments and biological substances in specimens from respiratory organs and thorax
R84.3Abnormal level of substances chiefly nonmedicinal as to source in specimens from respiratory organs and thorax
R84.4Abnormal immunological findings in specimens from respiratory organs and thorax
R84.5Abnormal microbiological findings in specimens from respiratory organs and thorax
R84.6Abnormal cytological findings in specimens from respiratory organs and thorax
R84.7Abnormal histological findings in specimens from respiratory organs and thorax
R84.8Other abnormal findings in specimens from respiratory organs and thorax
R84.9Unspecified abnormal finding in specimens from respiratory organs and thorax
Z16.1Resistance to beta lactam antibiotics
Z16.10Resistance to unspecified beta lactam antibiotics
Z16.11Resistance to penicillins
Z16.12Extended spectrum beta lactamase (ESBL) resistance
Z16.19Resistance to other specified beta lactam antibiotics
Z16.2Resistance to other antibiotics
Z16.20Resistance to unspecified antibiotic
Z16.21Resistance to vancomycin
Z16.22Resistance to vancomycin related antibiotics
Z16.23Resistance to quinolones and fluoroquinolones
Z16.24Resistance to multiple antibiotics
Z16.29Resistance to other single specified antibiotic
Z16.3Resistance to other antimicrobial drugs
Z16.30Resistance to unspecified antimicrobial drugs
Z16.31Resistance to antiparasitic drug(s)
Z16.32Resistance to antifungal drug(s)
Z16.33Resistance to antiviral drug(s)
Z16.34Resistance to antimycobacterial drug(s)
Z16.341Resistance to single antimycobacterial drug
Z16.342Resistance to multiple antimycobacterial drugs
Z16.35Resistance to multiple antimicrobial drugs
Z16.39Resistance to other specified antimicrobial drug

SNOMED
195742007Acute lower respiratory tract infection